Synopsis

This lecture aims at providing insight into radiomics to become a viable tool for glioma patients. Recent radiogenomics studies and methodologic improvements of radiomics as diagnostic, prognostic, and/or predictive biomarkers will be described. A concept of tumor heterogeneity and subregional radiomics will also be introduced.